Pylarify & neuraceq buy
Ended Awarded Last action
- Contract number
- 36C24123F0104
- Awardee
-
Progenics Pharmaceuticals Inc. UEI YLYKVRPCTCR3 Part of Lantheus Holdings, Inc.
- Awarding agency
-
Veterans Integrated Service Network 1
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $1,043,813
Award facts
- Contract value 100% obligated
- $1,043,813.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Sterling, VA, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $405,592 | |
| Funding Only Action | $252,610 | |
| Original award | $385,611 |
About this award
Progenics Pharmaceuticals Inc., a division of Lantheus Medical Imaging, Inc. and subsidiary of Lantheus Holdings, Inc., has been awarded a $1,043,813.36 firm fixed price delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule contract to provide Pylarify and Neuraceq to the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1, with performance in Sterling, Virginia through July 2024. This order calls for the delivery of Pylarify, a radioactive diagnostic agent used in positron emission tomography scans to detect prostate cancer, as well as Neuraceq, an investigational diagnostic agent for PET imaging of neurofibrillary tangles in Alzheimer's disease. Progenics Pharmaceuticals maintains indefinite delivery vehicles with the Department of Veterans Affairs and Defense Health Agency for prostate cancer medications and radiopharmaceuticals including Pylarify injection, with orders against these agreements valued from under $50,000 to over $5 million.
Quick answers
Who was awarded contract 36C24123F0104?
36C24123F0104 was awarded to Progenics Pharmaceuticals Inc. by Veterans Integrated Service Network 1 (Veterans Health Administration) on January 12, 2023.
How much is contract 36C24123F0104 worth?
The government has obligated $1,043,813 on 36C24123F0104.
Is contract 36C24123F0104 an order under another contract?
Yes. 36C24123F0104 is a delivery order under 36F79719D0170, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24123F0104 competed?
The extent of competition for 36C24123F0104 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award